Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,417 | -224,282 | -186,141 | -138,119 | -84,346 |
| Depreciation Amortization | 11,573 | 39,517 | 22,082 | 16,524 | 8,677 |
| Income taxes - deferred | N/A | 113 | N/A | N/A | N/A |
| Other Working Capital | 100,672 | -5,686 | -75,632 | -140,982 | 2,460 |
| Loans | 92,562 | -31,231 | -123,317 | -150,085 | 4,892 |
| Other Operating Activity | -67,841 | 294,812 | 410,633 | 356,536 | 104,188 |
| Operating Cash Flow | $142,383 | $73,243 | $47,625 | $-56,126 | $35,871 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,489 | -3,034 | -2,344 | -1,321 | -848 |
| Purchase Of Investment | -235,538 | -2,358,667 | -1,732,197 | -645,075 | -19,797 |
| Sale Of Investment | 248,984 | 1,670,953 | 1,226,545 | 901,093 | 225,320 |
| Net Loans | -44,600 | 1,450,121 | 1,175,699 | 1,006,099 | 470,957 |
| Other Investing Activity | 73,530 | 152,612 | 102,968 | 62,665 | 23,240 |
| Investing Cash Flow | $34,887 | $911,985 | $770,671 | $1,323,461 | $698,872 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 19,483 | -16,634 | -14,201 | -26,119 | -23,761 |
| Debt Issued | N/A | 538,050 | 538,050 | 495,750 | 275,000 |
| Debt Repayment | -48 | -1,478,995 | -1,037,643 | -957,593 | -345,046 |
| Common Stock Issued | 0 | 683,334 | 684,412 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 3,370 | 0 | 0 |
| Financing Cash Flow | $-167,145 | $-1,138,428 | $-691,988 | $-1,022,383 | $-243,858 |
| Beginning Cash Position | 411,583 | 564,783 | 564,783 | 564,783 | 564,783 |
| End Cash Position | 421,708 | 411,583 | 691,091 | 809,735 | 1,055,668 |
| Net Cash Flow | $10,125 | $-153,200 | $126,308 | $244,952 | $490,885 |
| Free Cash Flow | |||||
| Operating Cash Flow | 142,383 | 73,243 | 47,625 | -56,126 | 35,871 |
| Capital Expenditure | -7,489 | -3,034 | -2,344 | -1,321 | -848 |
| Free Cash Flow | 134,894 | 70,209 | 45,281 | -57,447 | 35,023 |